tiprankstipranks
Silexion Therapeutics (SLXN)
NASDAQ:SLXN
US Market
SLXN
Silexion Therapeutics
RESEARCH TOOLSreports

Silexion Therapeutics (SLXN) Balance Sheet

214 Followers

Silexion Therapeutics Balance Sheet

Silexion Therapeutics's total assets for Q4 2025 were $7.21M, a decrease of -37.88% from the previous quarter. SLXN total liabilities were $4.61M for the fiscal quarter, a -0.54% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Assets
$ 7.21M$ 2.86M$ 5.26M$ 9.33M$ 115.41M
Total Liabilities
$ 4.61M$ 6.85M$ 17.31M$ 16.41M$ 508.92K
Total Equity Gross Minority
$ 2.60M$ -3.99M$ -12.06M$ -7.08M$ 114.91M
Other Metrics
Currency in USD

Silexion Therapeutics Debt to Assets